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Arenaviruses are endemic to rodent populations, and zoonotic infection of humans can result in severe acute hemorrhagic fevers (43, 49). Up to 300,000 infections by Lassa fever
virus occur annually in Africa (44), and cases of Argentine,
Bolivian, and Venezuelan hemorrhagic fevers are regularly
reported in South America (49). Genetic diversification and
worldwide dissemination of arenaviruses with their rodent
hosts (51) provide opportunities for the continued emergence
of new pathogenic strains (10). Vaccines to prevent arenavirus
infection are not available, and treatment options for arenaviral hemorrhagic fevers are extremely limited. Ribavirin, a nonspecific antiviral agent with an incompletely understood mechanism of action, is currently used in severe and life-threatening
cases with mixed results (60). In the case of Argentine hemorrhagic fever caused by infection with Junı́n virus (JUNV), early
administration of human convalescent antiserum is the treatment of choice (17). There is an urgent need for effective
vaccines and therapeutic agents to combat endemic arenavirus
infections and to address biodefense concerns.
The arenaviruses are enveloped RNA viruses that encode
ambisense expression of four viral proteins (8). The nucleoprotein (N) and RNA-dependent RNA polymerase (L) associate with the two single-strand genomic RNA segments to
form the ribonucleoprotein core. Virion assembly occurs at the
plasma membrane (45) and is promoted by the matrix protein
(Z) (48, 59). Virus entry into the target cell is initiated by
binding of the envelope glycoprotein (GP-C) to a cell surface
receptor: ␣-dystroglycan in the Old World viruses (9, 34, 58)
and transferrin receptor 1 in the New World hemorrhagic fever
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viruses (50). Upon binding, the virion particle is endocytosed
(7), and fusion with cellular membrane is subsequently activated by acidic pH in the maturing endosome (11). As with
other class I viral fusion proteins (12, 13, 28, 29, 56), this
membrane fusion reaction is mediated by a series of conformational changes in GP-C that ultimately lead to formation of
a stable six-helix bundle structure (18, 21, 63). Intervention
strategies that target the steps in virus entry offer promise
for effective antiviral therapeutics. Indeed, small-molecule
arenavirus-specific entry inhibitors have recently been discovered (5).
GP-C is unique among class I envelope glycoproteins in that
the mature complex retains its cleaved signal peptide as an
essential element, together with the receptor-binding (G1) and
transmembrane fusion (G2) subunits. The stable, 58-residue
signal peptide (SSP) was initially identified as a component of
the Old World arenavirus GP-C complex (16, 19, 35) and
found to be essential for proteolytic maturation of the glycoprotein precursor in the Golgi body (1, 15, 35). Without SSP,
the G1-G2 precursor is specifically retained in the endoplasmic
reticulum (ER), in part through dibasic ER retrieval signals in
the cytoplasmic domain (CTD) of G2 (1). This acts as a quality
control mechanism to ensure that only the mature tripartite
GP-C complex is transported to the cell surface for virion
assembly. Unexpectedly, SSP incorporation in the GP-C complex also plays a crucial role in the activation of pH-dependent
membrane fusion activity (65). Furthermore, the unusual interplay between the ectodomains of SSP and G2 in membrane
fusion appears vulnerable to interference by the newly discovered small-molecule entry inhibitors (reference 5 and unpublished results). In this report, we provide biochemical and
genetic evidence for a high-affinity zinc-binding domain (ZBD)
in the CTD of G2 and discuss the implications of this novel
structure for SSP association in GP-C and its membrane fusion
activity.
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The envelope glycoprotein of the Junı́n arenavirus (GP-C) mediates entry into target cells through a pHdependent membrane fusion mechanism. Unlike other class I viral fusion proteins, the mature GP-C complex
retains a cleaved, 58-amino-acid signal peptide (SSP) as an essential subunit, required both for trafficking of GP-C
to the cell surface and for the activation of membrane fusion. SSP has been shown to associate noncovalently in
GP-C via the cytoplasmic domain (CTD) of the transmembrane fusion subunit G2. In this report we investigate the
molecular basis for this intersubunit interaction. We identify an invariant series of six cysteine and histidine
residues in the CTD of G2 that is essential for incorporation of SSP in the GP-C complex. Moreover, we show that
a CTD peptide fragment containing His-447, His-449, and Cys-455 specifically binds Zn2ⴙ at subnanomolar
concentrations. Together, these results suggest a zinc finger-like domain structure in the CTD of G2. We propose
that the remaining residues in the series (His-459, Cys-467, and Cys-469) form an intersubunit zinc-binding center
that incorporates Cys-57 of SSP. This unusual motif may act to retain SSP in the GP-C complex and position the
ectodomain loop of SSP for its role in modulating membrane fusion activity. The unique tripartite organization of
GP-C could provide novel molecular targets for therapeutic intervention in arenaviral disease.
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Based on the specific radioactivity of the reaction mixture (cpm/ml for the known
total concentration of Zn2⫹), the concentration of free and bound zinc is determined. Samples were counted using a Captus multichannel analyzer (Capintec)
and a single-well detector (2-ml capacity). The high-energy gamma emission of
65
Zn (950 to 1,200 keV) was detected at ⬃2.5% efficiency. Using this methodology, we were effectively limited to detecting zinc binding at concentrations of
ⱖ10 nM Zn2⫹ (i.e., ⱖ2,000 cpm per 2-ml sample).
Competitive metal ion binding studies. The specificity and selectivity of metal
ion binding were determined in a 5-ml equilibrium binding reaction mixture
containing 200 nM MBP-ZBD, 10 nM 65Zn2⫹, and a 10- to 10,000-fold excess of
CdCl2, CoCl2, CuCl2, MgCl2, or cold ZnCl2. A 50% inhibitory concentration
(IC50) for each metal ion was defined as that which competes for 50% of 65Zn2⫹
binding. Because of the excess of MBP-ZBD over 65Zn2⫹ in the reaction, the
relative IC50 is reported as a ratio of the competitor IC50 compared to that of
cold Zn2⫹.

RESULTS
Conserved cysteine and histidine residues in the CTD of G2.
Previous studies have demonstrated that the CTD of G2 is
essential for SSP incorporation in the mature GP-C complex
(1). GP-C mutants bearing deletions in this region are unable
to bind SSP, while chimeric proteins containing only the transmembrane domain and CTD of G2 associate with and require
SSP for transit through the Golgi body (1). To examine the role
of the G2 CTD in the assembly of the tripartite GP-C complex,
we compared amino acid sequences in the New World and Old
World arenaviruses (Fig. 1). Inspection of the CTD revealed a
well-conserved N-terminal region (P445 through G470) and a
variable C-terminal region (K471 through H485) that includes
dibasic ER retrieval motifs (1). Strikingly, the N-terminal region contains a series of six invariantly conserved cysteine and
histidine residues (Fig. 1). This array (H447, H449, C455,
H459, C467, and C469) was suggestive of the clustered cysteine
and histidine sequences found in many zinc finger proteins (27,
31, 33, 38).
Zinc fingers are compact protein domains that coordinate
one or more zinc ions (31). Tetrahedral ligation of Zn2⫹ serves
to stabilize protein folds and, in some cases, interprotein interactions (22, 27, 40). Structurally diverse, zinc fingers are
found in cellular proteins that function in DNA replication and
repair, transcriptional regulation, protein modification and
degradation, metabolism and signaling, vesicular trafficking,
and apoptosis (22, 31, 33, 38). It has been estimated that zinc
finger proteins represent 2% of the human genome coding
capacity (41). Zinc fingers are classified according to the amino
acids involved in zinc coordination (predominantly cysteines
and histidines) and by the size, topology, and folding of the
intervening loops (27, 33). The array of cysteine and histidine
residues in G2 generally conforms to the sequence motifs in
known zinc fingers, although the identical pattern is not represented in existing databases (InterPro database, European
Bioinformatics Institute). These considerations led us to investigate the zinc-binding properties of the CTD.
Zinc-binding activity of the G2 CTD. To characterize zinc
binding, we appended the entire CTD sequence (P445 to
H485) (Fig. 1) to the C terminus of MBP (New England Biolabs). The chimeric MBP-ZBD protein was expressed in E. coli
and purified using amylose resin affinity chromatography (Fig.
2). No Zn2⫹ was added during the purification procedure, and
the isolated protein was devoid of zinc (⬍0.03 mol per mol of
protein), as determined by reaction with 4-(2-pyridylazo)res-
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GP-C expression and MAbs. GP-C from the pathogenic JUNV strain MC2
(24) was expressed in Vero cells by cotransfection of pcDNA3.1 (Invitrogen)
plasmids encoding CD4sp-GPC (in which SSP is replaced by the conventional
signal peptide of CD4) and SSP-term (in which a stop codon is introduced
following the C-terminal SSP amino acid T58) (65). These components associate
in trans and reconstitute the native GP-C complex (15). Transient expression
utilized a recombinant vaccinia virus expressing T7 RNA polymerase (vTF7-3
[20]) and the T7 promoter of pcDNA3.1. The vaccinia virus-based ␤-galactosidase fusion reporter assay (46) was used to characterize the ability of GP-C to
mediate pH-dependent cell-cell fusion (65, 66). Mutations in GP-C were introduced by QuikChange mutagenesis (Stratagene), and all constructs were verified
by DNA sequencing. The murine monoclonal antibody (MAb) BF11 (53), directed to the G1 subunit of GP-C, was contributed by Tom Ksiasek and Tony
Sanchez (Special Pathogens Branch, CDC, Atlanta, GA) and obtained through
the NIH Biodefense and Emerging Infections Research Resources Repository.
GP-C expression was detected by immunoprecipitation of metabolically labeled complexes (65, 66). Briefly, cells were metabolically labeled using 50
Ci/ml of 35S-ProMix (Amersham Pharmacia Biotech) for 12 to 16 h. Cultures
were washed in physiological buffered saline and lysed using cold Tris-saline
buffer (50 mM Tris-HCl and 150 mM NaCl at pH 7.5) containing 1% Triton
X-100 nonionic detergent and protease inhibitors (1 g/ml each of aprotinin,
leupeptin, and pepstatin). The expressed glycoproteins were immunoprecipitated
from cleared lysates using MAb BF11 and protein A-Sepharose (Sigma). Proteins were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using NuPAGE 4 to 12% Bis-Tris gels (Invitrogen) and the
recommended sample buffer containing reducing agent. In some cases, the glycoproteins are deglycosylated by treatment with peptide–N-glycosidase F (New
England Biolabs) to facilitate resolution of the G1 and G2 subunits. Molecular
size markers included 14C-methylated Rainbow proteins (Amersham Pharmacia
Biotech). Radiolabeled proteins were visualized by phosphorimaging (Fuji FLA3000G) and analyzed using ImageGauge software (Fuji).
Purification of chimeric MBP. The sequence corresponding to the entire CTD
of G2 (encoding P445 to H485) was adapted by PCR and appended in frame at
the C terminus of maltose binding protein (MBP) using the KpnI polylinker site
in the plasmid pMAL-c2E (New England Biolabs), to generate pMBP-ZBD.
Expression of the chimeric MBP-ZBD protein in Escherichia coli K-12 strain
TB1 (New England Biolabs) was induced by the addition of isopropyl-␤-thiogalactopyranoside (IPTG) as recommended by New England Biolabs. Cell pellets
were frozen overnight and subsequently lysed using Bugbuster protein extraction
reagent (primary amine free; Novagen) in the presence of protease inhibitors (1
g/ml each of aprotinin, leupeptin, and pepstatin). Cleared extracts were incubated with amylose resin (New England Biolabs) in buffer containing 20 mM
HEPES (pH 6.8) and 200 mM NaCl for 2 h at 4°C with rocking. The resin was
then packed into a column and washed extensively with this buffer. Bound MBP
chimera was eluted by the addition of 10 mM maltose. The yield of purified
protein was 2 to 3 mg per g of wet cells.
Protein characterization. Proteins were analyzed by SDS-PAGE and visualized using SYPRO Red protein stain (Molecular Probes). Molecular size markers included Mark12 standards (Invitrogen). Protein concentrations were determined by the Coomassie Plus assay (Pierce) and corresponded to those
measured by optical density at 280 nm in 6 M GuHCl (14). Zinc content was
determined using the 4-(2-pyridylaxo)resorcinol (Aldrich) reagent in 4 M GuHCl
(30, 42).
Equilibrium binding studies. Prior to use for zinc binding, the purified proteins were dialyzed into buffer containing 50 mM HEPES (pH 6.8) and 20 mM
NaCl (HEPES-NaCl buffer) and incubated with an excess of tris(2-carboxyethyl)phosphine (TCEP; Pierce) for 20 min at room temperature in order to reduce
any disulfide bonds that form on exposure to air and in the absence of zinc.
TCEP does not bind metal ions and is thus uniquely suited for these studies (23,
32). We used 1 mM TCEP for 10 M protein and 0.1 mM for 200 nM protein.
These concentrations of TCEP were maintained throughout the subsequent
binding experiment. Radioactive zinc (65Zn) was obtained from Brookhaven
National Laboratory (U.S. Department of Energy) as a 2 mM solution of ZnCl2
in 0.1 N HCl. The specific activity is 2 Ci/mmol (batch Zn65-012506). Equilibrium dialysis studies were performed using a modified method in which unbound
ligand is determined by centrifugal ultrafiltration (26, 37). In a typical study, 200
nM of MBP-ZBD protein is incubated at room temperature with 10 nM of neat
65
Zn2⫹ in 5.0 ml of HEPES-NaCl buffer containing 0.1 mM TCEP. Equilibrium
binding is attained within 60 min (not shown). At this time, the reaction mixture
is sampled to determine the total amount of 65Zn2⫹, and the free 65Zn2⫹ is
determined by ultrafiltration (Amicon Ultra-4; 10,000-molecular-weight cutoff).
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orcinol (42). We also generated a mutant chimera (MBPnoZBD) in which the conserved CTD cysteine and histidine
residues were all replaced by amino acids that do not coordinate zinc ion (27). The three cysteines were changed to serine,
a similarly sized side chain that differs only at the hydroxyl
oxygen, whereas the three histidines were replaced by asparagine, another nitrogen-containing side chain. The MBPnoZBD protein was used to assess nonspecific zinc binding and
the potential role of the cysteine-histidine sequence motif.
Binding of radioactive 65Zn2⫹ was measured by a modified
equilibrium dialysis method in which centrifugal ultrafiltration
is used to determine the concentration of free ligand (26, 37).
In initial experiments, we incubated 10 M of MBP-ZBD with
100 nM 65ZnCl2 (Brookhaven National Laboratory; 2 Ci/

mmol) in 5.0 ml of HEPES-NaCl buffer containing 1 mM
TCEP, a nonthiol reducing agent that does not chelate metal
ions (23, 32). After 60 min of incubation with MBP-ZBD, less
than 1% of the input zinc radioactivity was found as free Zn2⫹
in the ultrafiltrate (Fig. 3, left), indicating complete binding. In
contrast, greater than 90% of the input Zn2⫹ from the MBPnoZBD binding reaction was free. Our results indicate that the

FIG. 2. Purified MBP chimeras containing the CTD of G2. The
purity of the chimeric proteins (500 ng each) was assessed using SDSPAGE. Wild-type MBP-ZBD and the individual mutants are indicated. C467Stop contains a stop codon at position 467, and MBPnoZBD includes the three cysteine and three histidine mutations. The
isoforms seen in the samples vary between analyses and likely reflect
different conformational states of the protein. Numbers at right are
molecular masses in kilodaltons.

FIG. 3. Specific binding of zinc ion to MBP-ZBD. MBP-ZBD and
MBP-noZBD (10 M, left, and 400 nM, right) were incubated with 100
⌴ and 10 nM 65Zn2⫹, respectively, as described in the text. Free
65
Zn2⫹ was determined by ultrafiltration. The counts per minute (cpm)
of free 65Zn2⫹ in the ultrafiltrate (1-ml or 2-ml sample, respectively)
are plotted. The total radioactivity in the binding reaction is used as
the full-scale value in each graph (10,000 and 2,000 cpm, respectively)
to demonstrate the relative proportion of unbound zinc.
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FIG. 1. The tripartite GP-C complex. A representation of the JUNV GP-C open reading frame is shown on top. Amino acids are numbered
from the initiating methionine, and cysteine residues () and potential glycosylation sites ( ) are marked. The signal peptidase and SKI-1/S1P (4,
35, 39) cleavage sites, and the resulting SSP, G1, and G2 subunits, are indicated. Within G2, the C-terminal transmembrane domain (TM) and CTD
(cyto) are marked, as are the N- and C-terminal heptad-repeat regions in the ectodomain (light gray shading). Below, we show a comparison of
arenavirus amino acid sequences in SSP and the CTD of G2. Sequences are from New World isolates Junı́n (D10072), Tacaribe (M20304),
Pichindé (U77601), Machupo (AY129248), and Sabiá (YP_089665) and Old World isolates Lassa-Nigeria (X52400), Mopeia (M33879), and
LCMV-Armstrong (M20869). The array of cysteine and histidine residues is highlighted in gray and numbered, and the two hydrophobic,
membrane-spanning regions in SSP (h1 and h2) are marked. A schematic drawing of the tripartite GP-C complex is shown at the lower right.
The model depicts the bitopic membrane topology of SSP in relation to the CTD of G2 (2). The myristoylation site (66) and fusion-critical Lys-33
residue (65) in SSP are indicated, as are the heptad-repeat regions in the G2 ectodomain (thicker lines). The N or C termini of the subunits are
labeled. The drawing is not to scale.
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FIG. 4. Zinc binding by MBP-ZBD mutants. Wild-type and mutant
MBP-ZBD proteins (400 nM in top panel and 200 nM in bottom
panel) were incubated with 10 nM 65Zn2⫹ as described in the text. The
cpm of free Zn2⫹ are plotted, and the full scale (2,000 cpm) represents
10 nM Zn2⫹. The results shown here are representative of six independent studies.

binding and the conserved residues in GP-C was determined by
individually replacing each cysteine and histidine residue in the
CTD with serine or asparagine, respectively. These mutations
were introduced into a GP-C construct (CD4sp-GPC) that
utilizes the conventional signal peptide of human CD4 for
expression of the G1-G2 precursor protein (1). Coexpression
of wild-type CD4sp-GPC in trans with an SSP polypeptide has
been shown to reconstitute the native GP-C complex (1, 15,
64). This trans-complementation method was chosen to obviate
experimental concerns regarding possible effects of the mutations on signal peptidase cleavage of full-length GP-C. The
GP-C complexes were metabolically labeled with 35S-ProMix
(Amersham Pharmacia Biotech) and immunoprecipitated using G1-specific MAb BF11 (53). SDS-PAGE analysis of the
wild-type GP-C complex reveals the association with SSP (Fig.
5, top) and the proteolytic maturation of the G1-G2 precursor
(Fig. 5, bottom). In contrast to the wild-type CD4sp-GPC,
none of the single cysteine and histidine mutants was able to
associate with SSP in trans (Fig. 5, top). Proteolytic maturation
of the G1-G2 precursor was also absent in the mutants (Fig. 5,
bottom), presumably reflecting the inability of the precursor to
transit through the Golgi body in the absence of SSP (1). As
anticipated, the mutants were unable to support membrane
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CTD of G2 can bind Zn2⫹ and that binding is dependent on
the intact array of cysteine and histidine residues. Furthermore, all the available Zn2⫹ was bound at a zinc concentration
of 100 nM. In other experiments using higher concentrations of
Zn2⫹, binding reached a plateau of ⬃0.3 mol zinc per mol of
protein (not shown). The substoichiometric amount of zinc
binding may reflect oxidative damage to the cysteines.
Efforts to attain subsaturating concentrations of Zn2⫹ and
determine an apparent dissociation constant (Kd) were ultimately limited by the relatively low specific activity of the zinc
isotope and the high affinity of binding (see Materials and
Methods). At the lowest practical zinc concentration (10 nM
65
Zn2⫹), binding by the MBP-ZBD protein remained quantitative even at low (200 to 400 nM) protein concentrations (Fig.
3, right). Based on the limits of the assay, we can conclude that
the Kd for Zn2⫹ binding to MBP-ZBD is likely to be significantly less than 1 nM (see below). The high-affinity interaction
of MBP-ZBD with Zn2⫹ is consistent with zinc finger binding (3).
The ability of MBP-ZBD to bind other divalent transitionmetal ions was determined by equilibrium dialysis using 10 nM
65
Zn2⫹ and an excess of Cd2⫹, Co2⫹, or Cu2⫹. The concentration of competitor ion required to inhibit Zn2⫹ binding by
50% (IC50) was used to assess the relative binding affinity. The
selectivity of binding to MBP-ZBD was determined as: Zn2⫹ ⬎
Cu2⫹ ⬎ Cd2⫹ ⬎⬎ Co2⫹. This order of preference conforms to
that of well-characterized zinc finger proteins (3, 36). The
respective IC50s for Cd2⫹, Co2⫹, and Cu2⫹ were 10-, 450-, and
5-fold that of Zn2⫹. Mg2⫹ did not compete for binding at
concentrations up to 100 M, demonstrating the requirement
for a transition-metal ion and the specificity of zinc binding.
Amino acid requirements for zinc-binding activity. To determine the role of specific cysteine and histidine side chains in
zinc binding, we introduced the respective serine and asparagine mutations individually into MBP-ZBD. The mutant proteins were affinity purified (Fig. 2), and 400 nM of each was
used to determine binding with 10 nM 65Zn2⫹ (Fig. 4, top). To
enhance the distinctions among the mutants, the assay was also
performed using 200 nM protein (Fig. 4, bottom). Under these
conditions, zinc binding was reduced markedly by the C455S
mutation and to a lesser extent by H447N and H449N (Fig. 4).
These results extrapolate to dissociation constants of 12 nM for
C455S and 1 to 2 nM for H447N and H449. We infer that these
three membrane-proximal residues (H447, H449, and C455)
are required for high-affinity binding of Zn2⫹ by MBP-ZBD.
Each is capable of coordinating zinc ion or may indirectly
contribute to formation of the properly folded zinc-binding
center. Interestingly, mutations in the three distal residues in
the array (H459N, C467S, and C469S) had little or no detectable effect on zinc binding in this assay.
To further dissect the sequence requirements for zinc binding, we truncated MBP-ZBD at position 467 to delete the two
C-terminal cysteines. On equilibrium dialysis, this C467Stop
mutant was indistinguishable from the wild-type protein in its
zinc binding (Fig. 4). Taken together with the wild-type binding
by the H459N mutant (above), we conclude that the membrane-proximal region of the array including H447, H449, and
C455 can fold autonomously to bind zinc ion with high affinity.
Conserved cysteines and histidines are required for SSP
incorporation in GP-C. The functional significance of zinc
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motif in the CTD of G2 and for its essential role in SSP
incorporation in the tripartite GP-C complex. Although many
viruses have adopted zinc fingers in their structural, regulatory,
and catalytic proteins (25, 47, 57, 62, 67), the motif has not
been described in a virus envelope glycoprotein. In addition to
its involvement in SSP association, the unusual ZBD in G2
protein may participate in functions typically served by the
CTD of viral envelope glycoproteins, including roles in the
intracellular trafficking and membrane fusion activity of GP-C
and in virion assembly and budding.
DISCUSSION

fusion (Fig. 6). Thus, CTD residues that are dispensable for
high-affinity zinc binding (H459, C467, and C469) as well as
those that are required (H447, H449, and C455) are each
essential for SSP incorporation in the GP-C complex.
Taken together, our studies provide strong biochemical evidence for a cysteine- and histidine-containing zinc-finger-like

FIG. 6. Membrane fusion activity of mutant GP-C complexes. pHdependent cell-cell fusion by the trans-complemented GP-C complex
was initiated by a pulse of medium adjusted to pH 5.0 and detected
using the recombinant vaccinia virus-based ␤-galactosidase reporter
assay (46) as previously described (65, 66). ␤-Galactosidase expression
was quantitated using the chemiluminescent substrate GalactoLite
Plus (Tropix), and the percentage of fusion relative to the wild-type
CD4sp-GPC complex (CD4sp ⫹ SSP) is indicated. Error bars represent ⫾1 standard deviation.
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FIG. 5. SSP association in GP-C complexes bearing mutations in
the G2 cysteine-histidine array. Vero cells were transfected to express
wild-type and mutant CD4sp-GPC in trans with wild-type SSP (⫹SSP)
(65). Metabolically labeled complexes were immunoprecipitated using
G1-specific MAb BF11 (53) and separated on NuPAGE (Invitrogen) 4
to 12% Bis-Tris gels under denaturing and reducing conditions (top
panel). The image has been darkened in order to visualize SSP. The
mature G1 and G2 subunits are not as well resolved as the glycoproteins and are rendered distinct on deglycosylation by peptide–N-glycosidase F (lower panel). The G1-G2 precursor and GP-C subunits are
labeled, as well as the 14C-labeled protein markers (in kilodaltons)
(Amersham Biosciences).

We have identified a novel zinc-binding activity in the CTD
of the arenavirus G2 fusion protein. An array of six cysteine
and histidine residues in the CTD is uniformly conserved in
New World and Old World arenaviruses, and peptide fragments containing the three membrane-proximal residues
(H447, H449, and C455) specifically bind Zn2⫹ at subnanomolar concentrations. Our results indicate that this region of the
cysteine-histidine array in the CTD of G2 can fold to form a
zinc-finger-like structural domain.
The three distal residues in the array (H459, C467, and
C469) are not required for high-affinity zinc binding. Nonetheless, all six residues in the array are essential for SSP incorporation in the mature GP-C complex; mutations at any of these
positions prevent association and render the envelope glycoprotein defective. This shared phenotype may of course arise
through a variety of mutational effects. Interestingly, however,
SSP association in GP-C is also abolished by mutation at an
absolutely conserved cysteine residue (C57) in the C-terminal
CTD of SSP (54, 64). Based on the bitopic membrane topology
of SSP in which both N and C termini reside in the cytosol (2)
(Fig. 1), this C-terminal region must be translocated from the
ER lumen following signal peptidase cleavage. With the exception of the inviolable C57, other residues in this short region (R55SCT58 in JUNV) are not conserved among the arenaviruses, and each can be mutated without effect on SSP
association (64). In light of the shared phenotype in mutants at
C57 in SSP and within the cysteine-histidine array of G2, we
speculate that H459, C467, and C469 may participate together
with C57 in forming an intersubunit zinc-binding center, possibly in conjunction with the membrane-proximal zinc center.
Although translocation of C57 into the cytosol is independent
of G2 (2), formation of a zinc finger motif bridging SSP and G2
may be needed to stabilize SSP incorporation in the GP-C
complex.
We have shown that peptide fragments including the membrane-proximal H447, H449, and C455 residues can bind Zn2⫹
with extremely high affinity and that single-amino-acid substitutions at these positions substantially reduce affinity to a range
that is consistent with the effects of single coordination-site
mutations in known zinc fingers (6, 55). The residual nanomolar affinity observed in these triply ligated mutants, however,
might suggest that zinc binding by the three distal cysteine and
histidine residues would also be detectable. The lack of binding
in our studies may simply reflect the inability of these residues
to coordinate zinc or the oxidative lability of the cysteines in
the recombinant peptide model in MBP-ZBD. Alternatively,
SSP may be important for zinc binding and formation of the
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proposed intersubunit zinc center. Because the C-terminal region of SSP is short and otherwise permissive to amino acid
changes (64), it appears that proper placement of the coordinating C57 side chain is promoted by additional sequence
elements that lie in the N-terminal region of SSP (54) or the
membrane-spanning domains of SSP and G2. Indeed, mutations in the second transmembrane domain of SSP that prevent
SSP association (2) might do so by perturbing the positioning
of C57 and thereby preventing formation of the intersubunit
zinc center. Structural studies are needed in order to further
assess the potential for zinc binding by H459, C467, and C469
and the proposed participation of C57 in SSP.
We should emphasize that specific interactions between SSP
and G2 are required for the membrane fusion activity of GP-C.
Recent studies have shown that mutations that diminish positive charge at K33 in the ectodomain loop of SSP increase the
H⫹ concentration needed for the activation of membrane fusion (65). These results suggest that that K33 interacts with
titratable residues in the ectodomain of G2 to modulate fusion
activation at acidic pH (65). Formation of a zinc-finger-like
structure on the cytosolic face of GP-C may be important in
positioning K33 and the ectodomain loop of SSP for this role.
In this regard, the localized interaction between SSP and the
G2 ectodomain in membrane fusion may provide a tractable
model for studying pH-induced activation of viral fusion and
the structural determinants on either side of the membrane
that control this fundamental function of virus envelope glycoproteins.
In proposing an intersubunit ZBD, we suggest a molecular
basis for the retention and positioning of SSP in the GP-C
complex for its role in pH-dependent membrane fusion. With
this report, the three structural proteins of the arenaviruses are
now known to contain a ZBD (52, 61). Biophysical and structural studies of the unusual ZBD in GP-C are needed to define
the zinc centers and characterize the requirements for folding.
A detailed understanding of the structure and function of the
unique SSP subunit in GP-C may suggest novel opportunities
for therapeutic intervention in arenavirus infection and hemorrhagic fevers.
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